Syros Pharmaceuticals, Inc. Quarterly Other Assets, Noncurrent in USD from Q4 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Syros Pharmaceuticals, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2015 to Q2 2024.
  • Syros Pharmaceuticals, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $1.46M, a 34.5% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $1.46M -$769K -34.5% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $1.55M -$3.1M -66.6% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.59M -$3.76M -70.2% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 $2.11M -$1.55M -42.4% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.23M -$3.09M -58.1% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $4.65M +$1.49M +47.3% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $5.35M +$2.41M +81.8% Dec 31, 2022 10-K 2024-03-27
Q3 2022 $3.67M +$1.26M +52.2% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $5.32M +$2.87M +118% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $3.16M +$1.41M +81% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $2.94M +$975K +49.6% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $2.41M +$1.4M +138% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $2.44M +$1.4M +134% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.74M +$967K +125% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $1.97M +$1.48M +301% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $1.01M +$78K +8.36% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.04M +$155K +17.4% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $776K -$327K -29.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $490K -$391K -44.4% Dec 31, 2019 10-K 2021-03-04
Q3 2019 $933K +$41K +4.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $889K +$26K +3.01% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 $1.1M +$228K +26.1% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $881K -$220K -20% Dec 31, 2018 10-K 2020-03-05
Q3 2018 $892K -$201K -18.4% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $863K +$13K +1.53% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $875K +$386K +78.9% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $1.1M +$619K +128% Dec 31, 2017 10-K 2019-03-07
Q3 2017 $1.09M +$650K +147% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $850K -$2.69M -76% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $489K Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $482K -$1.42M -74.6% Dec 31, 2016 10-K 2018-03-12
Q3 2016 $443K Sep 30, 2016 10-Q 2016-11-14
Q2 2016 $3.54M Jun 30, 2016 10-Q 2016-08-15
Q4 2015 $1.9M Dec 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.